Recent updates on the pathogenesis of inflammatory myopathies
J Musai, AL Mammen, I Pinal-Fernandez - Current Rheumatology Reports, 2024 - Springer
Abstract Purpose of Review This review aims to provide a comprehensive and updated
overview of autoimmune myopathies, with a special focus on the latest advancements in …
overview of autoimmune myopathies, with a special focus on the latest advancements in …
A comprehensive review of dermatomyositis treatments-from rediscovered classics to promising horizons
E Sevim, D Kobrin, M Casal-Dominguez… - Expert Review of …, 2024 - Taylor & Francis
Introduction Dermatomyositis (DM) is a rare inflammatory disease with diverse cutaneous
and systemic manifestations, often associated with myositis-specific antibodies. Managing …
and systemic manifestations, often associated with myositis-specific antibodies. Managing …
Pathological autoantibody internalisation in myositis
I Pinal-Fernandez, S Muñoz-Braceras… - Annals of the rheumatic …, 2024 - Elsevier
Objectives Autoantibodies targeting intracellular proteins are common in various
autoimmune diseases. In the context of myositis, the pathologic significance of these …
autoimmune diseases. In the context of myositis, the pathologic significance of these …
An update on autoantibodies in the idiopathic inflammatory myopathies
NA Allameen, AI Ramos-Lisbona… - Nature Reviews …, 2024 - nature.com
Myositis-specific autoantibodies (MSAs) have become pivotal biomarkers for idiopathic
inflammatory myopathies and have revolutionized understanding of the heterogeneous …
inflammatory myopathies and have revolutionized understanding of the heterogeneous …
Antimelanoma differentiation antigen 5-positive dermatomyositis: an update
X Lu, Q Peng, G Wang - Current Opinion in Rheumatology, 2024 - journals.lww.com
Current Opinion in Rheumatology Log in or Register Subscribe to journalSubscribe Get new issue
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe …
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe …
[PDF][PDF] An update on myositis autoantibodies and insights into pathogenesis
G Wang, NJ McHugh - Clinical and Experimental …, 2024 - clinexprheumatol.org
Myositis-specific autoantibodies (MSAs) are hallmarks of idiopathic inflammatory
myopathies (IIMs) and have become increasing valuable in disease diagnosis, phenotyping …
myopathies (IIMs) and have become increasing valuable in disease diagnosis, phenotyping …
Comparative B cell epitope profiling in Japanese and North American cohorts of MDA5+ dermatomyositis patients reveals a direct association between immune …
K Yamaguchi, P Poland, L Zhu… - …, 2024 - academic.oup.com
Objectives Anti-melanoma differentiation–associated gene 5 antibody–positive (MDA5+) DM
patients exhibit clinical features that vary by geographical and ethnic/genetic distribution …
patients exhibit clinical features that vary by geographical and ethnic/genetic distribution …
[HTML][HTML] Pathogenic autoantibody internalization in myositis
I Pinal-Fernandez, S Munoz-Braceras… - medRxiv, 2024 - ncbi.nlm.nih.gov
Objectives: Myositis is a heterogeneous family of autoimmune muscle diseases. As myositis
autoantibodies recognize intracellular proteins, their role in disease pathogenesis has been …
autoantibodies recognize intracellular proteins, their role in disease pathogenesis has been …